- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Aarey Drugs and Pharmaceuticals Limited has announced a board meeting outcome, confirming the issuance of 50,00,000 warrants convertible into equity shares on a preferential basis, pending shareholder approval. Additionally, an Extraordinary General Meeting (EGM) is set for 02nd January 2025 to secure necessary approvals. The board also reappointed Mr. Lalit Radha Krishna Tulsiani and Mr. Anil Mandal as Independent Directors for five-year terms, starting 29th January 2025 and 01st July 2025, respectively.
This strategic move could strengthen the company's capital structure and governance, potentially enhancing investor sentiment with a positive outlook. The diluted share capital may create further growth opportunities as the company advances its objectives.
All announcements from Aarey Drugs & Pharmaceuticals Limited